KIF2B and central nervous system cancer: A total of 40 differentially expressed KIFs with p < 0.001 were screened, among which 10 KIFs, including KIF17, KIF1C, KIF12, KIF5C, KIFC2, KIF19, KIF25, KIF1A, KIF5A, and KIF2B were found decreased expression in tumor samples (Figure 2A), while other 30 KIFs were significantly upregulated in glioma (Figure 2B–D).